These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38695888)

  • 41. Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.
    Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE
    Clin Pharmacokinet; 2020 Nov; 59(11):1357-1392. PubMed ID: 32783100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software.
    Kirubakaran R; Stocker SL; Carlos L; Day RO; Carland JE
    Ther Drug Monit; 2021 Dec; 43(6):736-746. PubMed ID: 34126624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
    Andreu F; Colom H; Elens L; van Gelder T; van Schaik RHN; Hesselink DA; Bestard O; Torras J; Cruzado JM; Grinyó JM; Lloberas N
    Clin Pharmacokinet; 2017 Aug; 56(8):963-975. PubMed ID: 28050888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.
    Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL
    Br J Clin Pharmacol; 2023 Mar; 89(3):1162-1175. PubMed ID: 36239542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
    Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
    Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.
    Fruit D; Rousseau A; Amrein C; Rollé F; Kamar N; Sebbag L; Redonnet M; Epailly E; Marquet P; Prémaud A
    Clin Pharmacokinet; 2013 Apr; 52(4):277-88. PubMed ID: 23400901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
    Scholten EM; Cremers SC; Schoemaker RC; Rowshani AT; van Kan EJ; den Hartigh J; Paul LC; de Fijter JW
    Kidney Int; 2005 Jun; 67(6):2440-7. PubMed ID: 15882290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
    Rong Y; Mayo P; Ensom MHH; Kiang TKL
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach.
    Nanga TM; Doan TTP; Marquet P; Musuamba FT
    Br J Clin Pharmacol; 2019 Dec; 85(12):2793-2823. PubMed ID: 31471970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
    Lemaitre F; Antignac M; Fernandez C
    Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.
    Oteo I; Lukas JC; Leal N; Suarez E; Valdivieso A; Gastaca M; Ortiz de Urbina J; Calvo R
    Eur J Clin Pharmacol; 2013 Jan; 69(1):65-74. PubMed ID: 22660442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients.
    Li D; Lu W; Zhu JY; Gao J; Lou YQ; Zhang GL
    J Clin Pharm Ther; 2007 Oct; 32(5):505-15. PubMed ID: 17875118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Donor and Recipient
    Shao J; Wang C; Fu P; Chen F; Zhang Y; Wei J
    Ann Pharmacother; 2020 Jul; 54(7):652-661. PubMed ID: 31888346
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of Bayesian Forecasting Methods for Prediction of Tacrolimus Exposure Using Samples Taken on Two Occasions in Adult Kidney Transplant Recipients.
    Brooks E; Tett SE; Isbel NM; McWhinney B; Staatz CE
    Ther Drug Monit; 2021 Apr; 43(2):238-246. PubMed ID: 32932413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.